Healthcare Services

Coronary Artery Disease Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

March 31, 2026March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Coronary Artery Disease Market At The End Of The 2026–2030 Forecast Period?

The market size for coronary artery disease has expanded swiftly in recent years. It is anticipated to increase from $31.88 billion in 2025 to $35.27 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.6%. This historic period’s growth can be linked to the high prevalence of cardiovascular disease, sedentary lifestyles, tobacco consumption, limited preventive care awareness, and hospital-centric treatment models.

The market size for coronary artery disease is anticipated to undergo substantial growth in the upcoming years. This market is set to expand to $53.97 billion by 2030, with a compound annual growth rate (CAGR) of 11.2%. The expansion during this forecast period is attributable to a burgeoning global elderly population, escalating rates of obesity, enhanced diagnostic technologies, the advancement of preventive cardiology, and greater access to healthcare. Significant developments expected in the forecast period encompass a heightened emphasis on early disease detection, the increasing application of combination drug therapies, the proliferation of lifestyle modification programs, the broader availability of minimally invasive treatments, and the integration of cardiac rehabilitation services.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12052&type=smp

Which Market Drivers Are Supporting The Expansion Of The Coronary Artery Disease Market?

The increasing incidence of coronary artery disease is anticipated to drive expansion in the coronary artery disease market in the forthcoming years. Coronary artery disease (CAD) defines a health condition marked by the constriction or obstruction of the coronary arteries, vital for supplying blood to the heart muscle. The growing number of coronary artery disease cases stems from evolving dietary habits, heightened stress levels, insufficient physical activity, obesity, advancing age, among other factors. Treatment for coronary artery disease involves medications such as clopidogrel, ticagrelor, warfarin, and heparin, alongside procedures like coronary artery bypass grafting, angioplasty, and stenting. As an illustration, in October 2025, data from the Australian Institute of Health and Welfare, an Australian government body, indicated that in 2023, approximately 2,700 acute coronary events affected First Nations people aged 25 and older. When accounting for population age structure, this incidence rate was 2.8 times greater compared to non-Indigenous people. Consequently, the growing prevalence of coronary artery disease is projected to stimulate the coronary artery disease market throughout the forecast period.

What Segment Types Make Up The Coronary Artery Disease Market?

The coronary artery disease market covered in this report is segmented –

1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments

2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

4) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Medication: Antiplatelet Agents, Beta-Blockers, Statins, ACE Inhibitors

2) By Surgery: Coronary Artery Bypass Grafting, Angioplasty And Stenting, Heart Valve Surgery

3) By Additional Therapy: Cardiac Rehabilitation, Lifestyle Modification Programs, Alternative Therapies

4) By Other Treatments: Gene Therapy, Stem Cell Therapy, Innovative Devices

How Are Trends Shaping The Direction Of The Coronary Artery Disease Market?

Leading companies operating within the coronary artery disease market are concentrating on developing innovative products, such as drug-coated balloon catheters, to expand their market revenues. Drug-coated balloon catheters are medical devices employed in interventional cardiology to address narrowed or blocked blood vessels, particularly in the context of coronary artery disease or peripheral artery disease. For instance, in March 2024, Boston Scientific Corporation, a US-based medical device company, announced the US Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB), indicated for treating coronary in-stent restenosis (ISR) in patients with coronary artery disease. ISR describes the obstruction or narrowing of a stented vessel due to plaque or scar tissue. The AGENT DCB presents a specialized treatment option for the challenging condition of in-stent restenosis (ISR), thereby addressing a significant unmet medical need. It is specifically engineered for treating ISR, in addition to previously untreated small vessel coronary disease. Available in Europe, parts of Asia Pacific, and Latin America, the AGENT DCB delivers a targeted solution for these complex cardiovascular conditions.

Who Are The Key Players Driving Competition In The Coronary Artery Disease Market?

Major companies operating in the coronary artery disease market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Kowa Pharmaceuticals America Inc., Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V.

Read the full coronary artery disease market report here:

https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

How Is The Coronary Artery Disease Market Distributed Across Key Geographic Regions?

North America was the largest region in the coronary artery disease market in 2025. The regions covered in the coronary artery disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Coronary Artery Disease Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12052&type=smp

Browse Through More Reports Similar to the Global Coronary Artery Disease Market 2026, By The Business Research Company

Coronary Artery Disease Global Market Report

https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

Aortic Stent Grafts Global Market Report

https://www.thebusinessresearchcompany.com/report/aortic-stent-grafts-global-market-report

Heart Transplant Global Market Report

https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795